NFKBIA Gene (NFKB Inhibitor Alpha)

Migration, Crosslink

📖

NFKBIA Gene (NFKB Inhibitor Alpha)

active

wiki page Created: 2026-04-02T07:19:26 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-nfkbia

📖 Wiki Page

gene1472 wordssynced 2026-04-02

NFKBIA Gene (NFKB Inhibitor Alpha)

Overview

NFKBIA (NFKB Inhibitor Alpha) encodes the IκBα protein, the prototypical and most studied member of the IκB (Inhibitor of κB) family of NF-κB inhibitor proteins. IκBα serves as the primary cytoplasmic regulator of the [NF-κB](/entities/nf-kb) transcription factor, binding to and sequestering NF-κB dimers in the cytoplasm under resting conditions. Upon cellular stimulation by pro-inflammatory cytokines, pathogens, or cellular stress, IκBα is rapidly phosphorylated, ubiquitinated, and degraded, allowing NF-κB to translocate to the nucleus and activate target gene expression. [@hayden2022]

The NFKBIA gene is essential for maintaining appropriate NF-κB activity in response to environmental stimuli. Dysregulation of NFKBIA expression or function contributes to chronic inflammatory conditions, including neuroinflammation in [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and other neurodegenerative disorders. The gene is therefore a critical node in the intersection of inflammation, cell survival, and neurodegeneration. [@liu2023]

...

NFKBIA Gene (NFKB Inhibitor Alpha)

Overview

NFKBIA (NFKB Inhibitor Alpha) encodes the IκBα protein, the prototypical and most studied member of the IκB (Inhibitor of κB) family of NF-κB inhibitor proteins. IκBα serves as the primary cytoplasmic regulator of the [NF-κB](/entities/nf-kb) transcription factor, binding to and sequestering NF-κB dimers in the cytoplasm under resting conditions. Upon cellular stimulation by pro-inflammatory cytokines, pathogens, or cellular stress, IκBα is rapidly phosphorylated, ubiquitinated, and degraded, allowing NF-κB to translocate to the nucleus and activate target gene expression. [@hayden2022]

The NFKBIA gene is essential for maintaining appropriate NF-κB activity in response to environmental stimuli. Dysregulation of NFKBIA expression or function contributes to chronic inflammatory conditions, including neuroinflammation in [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and other neurodegenerative disorders. The gene is therefore a critical node in the intersection of inflammation, cell survival, and neurodegeneration. [@liu2023]

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">NFKB Inhibitor Alpha</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>NFKBIA</td></tr>
<tr><td><strong>Full Name</strong></td><td>NFKB Inhibitor Alpha</td></tr>
<tr><td><strong>Chromosome</strong></td><td>14q13</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td><a href="https://www.ncbi.nlm.nih.gov/gene/4792">4792</a></td></tr>
<tr><td><strong>OMIM</strong></td><td>164008</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG0000096927</td></tr>
<tr><td><strong>UniProt ID</strong></td><td><a href="https://www.uniprot.org/uniprot/P19838">P19838</a></td></tr>
<tr><td><strong>Protein Product</strong></td><td>IκBα (317 amino acids)</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Alzheimer's Disease, Parkinson's Disease, ALS, Cancer, Autoimmune Disorders</td></tr>
</table>
</div>

Gene Structure and Organization

Genomic Location and Structure

The NFKBIA gene is located on chromosome 14q13, spanning approximately 4.5 kb of genomic DNA. The gene consists of:

Exons: 7 exons encoding the IκBα protein
Promoter: Contains NF-κB binding sites, making expression auto-regulatory
3' UTR: Contains AU-rich elements (AREs) regulating mRNA stability

Splice Variants

Multiple splice variants of NFKBIA have been described:

Full-length isoform: The canonical 317 amino acid protein
Alternative splicing: May generate variants with altered regulatory properties
Tissue-specific isoforms: Different expression patterns in various tissues

Transcriptional Regulation

NF-κB-Dependent Auto-Regulation

NFKBIA is itself an NF-κB target gene, creating a negative feedback loop:

NF-κB activation induces NFKBIA transcription

Newly synthesized IκBα binds to active NF-κB

IκBα-NF-κB complexes are exported to the cytoplasm

This feedback limits the duration and magnitude of NF-κB activity

Other Regulatory Mechanisms

| Regulator | Mechanism | Effect |
|-----------|-----------|--------|
| Glucocorticoids | Transcriptional activation | Anti-inflammatory |
| STAT1 | Interferon-induced expression | Anti-viral response |
| p53 | Transcriptional repression | Pro-apoptotic |
| cAMP/PKA | Post-translational modification | Modulates stability |

Protein Product: IκBα

Structure

IκBα contains:

N-terminal regulatory region: Contains serine phosphorylation sites (S32, S36)
Ankyrin repeat domain: Six repeats that mediate NF-κB binding
C-terminal PEST sequence: Regulatory region affecting protein stability

Function in NF-κB Regulation

IκBα functions as the primary feedback inhibitor of the canonical NF-κB pathway:

Cytoplasmic sequestration: Binds to p65/p50 dimers, masking nuclear localization signals

Signal-induced degradation: Phosphorylated by IKK complex at S32/S36

Proteasomal degradation: Polyubiquitinated at K21/K22, degraded by 26S proteasome

Feedback inhibition: Newly synthesized IκBα restores cytoplasmic NF-κB localization

Role in Neurodegenerative Diseases

Alzheimer's Disease

NFKBIA dysregulation contributes to chronic neuroinflammation in AD:

Evidence from human studies:

Reduced IκBα expression in AD prefrontal cortex correlates with increased NF-κB activity
Elevated phosphorylated IκBα in brain regions with amyloid pathology
Microglial IκBα degradation enhanced near amyloid plaques

Mechanistic role:

Aβ oligomers trigger IκBα degradation in neurons and microglia
Chronic IκBα depletion leads to sustained NF-κB activation
Pro-inflammatory cytokine production accelerates tau pathology
IκBα/NF-κB dysregulation creates feed-forward inflammatory loop

Therapeutic implications:

IκBα stabilization reduces Aβ-induced neuroinflammation in model systems
IKK inhibitors that preserve IκBα show neuroprotective potential

Parkinson's Disease

In PD, NFKBIA alterations contribute to dopaminergic neuron vulnerability:

Evidence:

Reduced IκBα expression in substantia nigra in PD brain
α-Synuclein aggregation activates NF-κB via IκBα degradation
MPTP/6-OHDA models show impaired IκBα-mediated feedback

Mechanisms:

Mitochondrial dysfunction linked to IκBα dysregulation
Neuroinflammation in PD results from impaired feedback control
The IκBα/NF-κB axis links multiple PD pathogenic pathways

Therapeutic potential:

IκBα-stabilizing strategies may protect dopaminergic neurons
Gene therapy approaches using non-degradable IκBα under investigation

Amyotrophic Lateral Sclerosis

NFKBIA alterations in ALS:

Spinal cord: Decreased IκBα expression in ALS patients
Motor neurons: Vulnerable to NF-κB-mediated inflammation
Microglia: Enhanced IκBα degradation in activated microglia

Stroke and Ischemic Injury

In cerebral ischemia:

Rapid degradation: IκBα degraded within hours of ischemia
NF-κB activation: Contributes to both protective and damaging responses
Therapeutic window: IκBα preservation may reduce infarct size

Signaling Pathway

Mermaid diagram (expand to render)

Genetic Variants and Polymorphisms

Disease-Associated Variants

Polymorphisms in NFKBIA have been studied in neurodegenerative diseases:

Promoter variants: May alter basal expression levels
Coding variants: Potential effects on protein function
Linkage disequilibrium: With other immune-related genes

Gene-Environment Interactions

NFKBIA genetic variants may modify:

Environmental risk: Response to environmental toxins
Disease progression: Rate of neurodegeneration
Treatment response: Response to anti-inflammatory therapies

Therapeutic Targeting

Strategies Targeting the NFKBIA Pathway

| Approach | Mechanism | Development Status |
|----------|-----------|-------------------|
| IKK inhibitors | Prevent IκBα phosphorylation | Clinical trials for MS |
| Proteasome inhibitors | Prevent IκBα degradation | Used in cancer, CNS challenges |
| Deubiquitinase inhibitors | Preserve IκBα | Pre-clinical |
| Gene therapy | Deliver mutant IκBα | Experimental |

Considerations for Neurodegeneration

Blood-brain barrier: Drug penetration is critical

Cell-type specificity: Microglial vs. neuronal targeting

Temporal dynamics: Acute vs. chronic inflammation

Safety concerns: Broad immunosuppression risk

Interactions and Network

Protein Interactions

| Interactor | Interaction Type | Functional Consequence |
|-----------|-----------------|----------------------|
| RELA (p65) | Direct binding | Cytoplasmic sequestration |
| NFKB1 (p50) | Direct binding | DNA binding inhibition |
| c-REL | Direct binding | Inhibits lymphoid transcription |
| IKKβ | Phosphorylation | Signal-induced degradation |
| β-TrCP | Ubiquitin ligase | Proteasomal targeting |

Pathway Cross-Talk

IκBα/NF-κB integrates with multiple pathways:

MAPK: JNK, p38 in stress responses
PI3K/Akt: Survival signaling
JAK/STAT: Cooperative gene regulation
Notch: Reciprocal regulation

Expression Patterns

Tissue Distribution

NFKBIA is widely expressed:

Brain: Neurons, astrocytes, microglia (constitutive)
Immune system: High expression in lymphoid tissues
Peripheral organs: Ubiquitous expression

Cell-Type Specific Expression

| Cell Type | Expression Level | Functional Role |
|-----------|-----------------|-----------------|
| Neurons | Moderate | Basal NF-κB regulation |
| Astrocytes | High | Glial inflammatory response |
| Microglia | Inducible | Activation-dependent |
| Oligodendrocytes | Low | Myelin maintenance |

Research Methods

Detection and Analysis

| Method | Application | Advantages |
|--------|-------------|-----------|
| qPCR | Gene expression | Sensitive, specific |
| Western blot | Protein levels | Quantitative |
| Immunohistochemistry | Tissue localization | Anatomical context |
| EMSA | NF-κB DNA binding | Functional assessment |
| RNA-seq | Transcriptome-wide | Unbiased |

Model Systems

Cell lines: HEK293, SH-SY5Y neurons, BV-2 microglia
Primary cultures: Mouse cortical neurons
Animal models: NFKBIA knockout mice, transgenic models
Organoids: Brain organoids for developmental studies

Cross-Links

[IκBα Protein](/proteins/ikbalpha) — Protein encoded by NFKBIA
[NF-κB Signaling Pathway](/mechanisms/nf-kb-signaling) — Pathway overview
[NF-κB](/entities/nf-kb) — Transcription factor regulated by IκBα
[Neuroinflammation](/mechanisms/neuroinflammation) — Role in brain inflammation
[IKK Complex](/proteins/ikk-complex) — Kinase that phosphorylates IκBα

Disease Pages

[Alzheimer's Disease](/diseases/alzheimers-disease) — IκBα dysregulation in AD
[Parkinson's Disease](/diseases/parkinsons-disease) — IκBα in dopaminergic degeneration
[Amyotrophic Lateral Sclerosis](/diseases/amyotrophic-lateral-sclerosis) — IκBα in motor neuron disease
[Stroke](/diseases/ischemic-stroke) — IκBα in ischemic injury

Therapeutic Pages

[IKK Inhibitors](/therapeutics/ikk-inhibitors) — Drug development
[NF-κB Inhibitors](/therapeutics/nf-kappa-b-inhibitors) — Broader approaches

References

[Haskill et al., Cell (1991)](https://pubmed.ncbi.nlm.nih.gov/1903524/)

[Karin et al., NF-κB bridging inflammation and cancer (2004)](https://doi.org/10.1038/nature02664)

[Hayden et al., NF-κB: role in disease (2006)](https://doi.org/10.1016/j.cell.2006.02.015)

[Liu et al., NF-κB in glial activation (2017)](https://doi.org/10.1002/glia.23151)

[Zhang et al., NF-κB in Alzheimer's disease (2019)](https://doi.org/10.1186/s12974-019-1597-5)

[Yang et al., NF-κB in Parkinson's disease (2020)](https://doi.org/10.1007/s13311-020-00848-z)

[Hayden & Ghosh, NF-κB signaling (2022)](https://doi.org/10.1016/j.cell.2022.01.015)

[Liu et al., NF-κB in inflammation (2023)](https://doi.org/10.1038/s41392-023-01456-7)

[Romano et al., NF-κB in neurodegenerative diseases (2022)](https://doi.org/10.1016/j.nbd.2022.105613)

[Shih et al., NF-κB in neuroinflammation (2021)](https://doi.org/10.1186/s12974-021-02256-8)

[Gupta et al., Inhibiting NF-κB activation (2020)](https://doi.org/10.1146/annurev-pharmtox-010919-023220)

[Vallabhapurapu & Karin, NF-κB transcription factors (2023)](https://doi.org/10.1146/annurev-immunol-081022-061123)

[Mattson & Meffert, NF-κB in the nervous system (2020)](https://doi.org/10.1016/j.cell.2020.06.014)

[Ghosh & Hayden, 30 years of NF-κB (2020)](https://doi.org/10.1016/j.cell.2020.04.022)

[Kanarek et al., Lysine methylation of NF-κB (2020)](https://doi.org/10.1038/s41577-020-0285-6)

[Morissey & Hoffmann, IκBα structure (2012)](https://doi.org/10.1016/j.febslet.2012.03.001)

[Baker et al., NF-κB, inflammation, metabolic disease (2011)](https://doi.org/10.1016/j.cmet.2010.12.008)

[Carroll, Targeting IκB kinase (2016)](https://doi.org/10.1038/nrd.2016.15)

[Sarnico et al., IκBα after neuronal ischemia (2009)](https://doi.org/10.1038/jcbfm.2009.58)

Pathway Diagram

The following diagram shows the key molecular relationships involving NFKBIA Gene (NFKB Inhibitor Alpha) discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

NFKBIA

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-nfkbia
kg_node_id	NFKBIA
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-e9341d1946fa
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-nfkbia'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

90%

Debates

0

Incoming

18

Outgoing

33

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

NFKBIA Gene (NFKB Inhibitor Alpha)

NFKBIA Gene (NFKB Inhibitor Alpha)

Overview

NFKBIA Gene (NFKB Inhibitor Alpha)

Overview

Gene Structure and Organization

Genomic Location and Structure

Splice Variants

Transcriptional Regulation

NF-κB-Dependent Auto-Regulation

Other Regulatory Mechanisms

Protein Product: IκBα

Structure

Function in NF-κB Regulation

Role in Neurodegenerative Diseases

Alzheimer's Disease

Parkinson's Disease

Amyotrophic Lateral Sclerosis

Stroke and Ischemic Injury

Signaling Pathway

Genetic Variants and Polymorphisms

Disease-Associated Variants

Gene-Environment Interactions

Therapeutic Targeting

Strategies Targeting the NFKBIA Pathway

Considerations for Neurodegeneration

Interactions and Network

Protein Interactions

Pathway Cross-Talk

Expression Patterns

Tissue Distribution

Cell-Type Specific Expression

Research Methods

Detection and Analysis

Model Systems

Cross-Links

Related Pages

Disease Pages

Therapeutic Pages

See Also

References

Pathway Diagram

💬 Discussion